Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Arcellx (NASDAQ:ACLX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Arcellx Charts.

Arcellx (NASDAQ:ACLX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Arcellx Charts.

Arcellx Inc News

Form 8-K - Current report
Monday 9 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
Sunday 8 December 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Thursday 7 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study
Tuesday 5 November 2024 (2 months ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 22 October 2024 (2 months ago) • Edgar (US Regulatory)

More Arcellx Inc News Articles

Anavex Life Sciences

Accredited Solutions (PK)

Digital Brand Media and ... (PK)

Rennova Health (CE)

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Lightwave Logic

North Bay Resources (PK)

Code Green Apparel (PK)

Intergrated Cannabis Sol... (PK)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions